CAINI, PATRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.123
EU - Europa 2.907
AS - Asia 1.671
SA - Sud America 177
AF - Africa 52
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 13
Totale 9.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.053
RU - Federazione Russa 1.042
SG - Singapore 489
IT - Italia 483
CN - Cina 360
PL - Polonia 347
HK - Hong Kong 309
SE - Svezia 283
IE - Irlanda 255
VN - Vietnam 173
BR - Brasile 134
KR - Corea 125
DE - Germania 115
FI - Finlandia 83
FR - Francia 83
GB - Regno Unito 69
UA - Ucraina 67
JP - Giappone 47
TR - Turchia 43
CA - Canada 42
IN - India 42
AU - Australia 37
CI - Costa d'Avorio 24
NL - Olanda 19
AR - Argentina 15
MX - Messico 14
BD - Bangladesh 13
BE - Belgio 13
JO - Giordania 13
EC - Ecuador 10
IQ - Iraq 10
CO - Colombia 9
CH - Svizzera 8
ZA - Sudafrica 7
CZ - Repubblica Ceca 6
ES - Italia 6
ID - Indonesia 6
PK - Pakistan 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
NG - Nigeria 5
RO - Romania 5
UZ - Uzbekistan 5
MA - Marocco 4
DK - Danimarca 3
HN - Honduras 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
PH - Filippine 3
PS - Palestinian Territory 3
AM - Armenia 2
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
KG - Kirghizistan 2
MT - Malta 2
PR - Porto Rico 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
EE - Estonia 1
GR - Grecia 1
LK - Sri Lanka 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 9.968
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.113
Ashburn 465
Fairfield 394
Singapore 348
Warsaw 347
San Jose 318
Chandler 280
Dublin 255
Hong Kong 252
Woodbridge 201
Seattle 178
Wilmington 165
Cambridge 156
Beijing 150
Houston 131
Seoul 125
Ann Arbor 115
Jacksonville 104
Milan 84
Buffalo 80
Council Bluffs 77
The Dalles 75
Los Angeles 62
Princeton 61
Ho Chi Minh City 54
Lauterbourg 52
Altamura 50
Boston 48
Tokyo 47
Lawrence 45
Boardman 44
Hanoi 40
Dallas 39
Rome 38
Izmir 35
Melbourne 35
Bremen 34
Florence 34
Munich 31
New York 30
Medford 29
Mumbai 27
Abidjan 24
Shanghai 21
Hefei 20
San Diego 20
Paris 19
Phoenix 18
Turku 18
Washington 16
Moscow 15
Brussels 13
Falls Church 13
Naples 13
Norwalk 13
São Paulo 12
Toronto 11
Brooklyn 10
Chicago 10
London 10
Turin 10
Verona 10
Bern 8
Bologna 8
Brasília 8
Frankfurt am Main 8
Helsinki 8
Kent 8
Redondo Beach 8
Da Nang 7
Atlanta 6
Bari 6
Figino 6
Hillsboro 6
Orem 6
Palermo 6
Salerno 6
Stockholm 6
West Jordan 6
Abuja 5
Auburn Hills 5
Baghdad 5
Clifton 5
Columbus 5
Frankfurt Am Main 5
Mexico City 5
Modena 5
Montreal 5
Rio de Janeiro 5
San Francisco 5
Tashkent 5
Venice 5
Andover 4
Barnet 4
Bergamo 4
Brescia 4
Brno 4
Cluj-Napoca 4
Denver 4
Jakarta 4
Totale 6.758
Salva come PNG Salva come JPEG
Nome #
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 321
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 272
The effects of phosphate on the contraction of single skeletal myofibrils 243
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 236
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 227
Association Between Persistent Lymphatic Infection By Hepatitis C Virus After Antiviral Treatment And Mixed Cryoglobulinemia 219
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 214
Host genetic determinants in HCV-related mixed cryoglobulinemia 213
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 205
Host genetic determinants in HCV-related mixed cryoglobulinemia 201
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 200
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 195
Analysis of HCV persistence in patients with sustained virological response 195
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 194
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 188
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 186
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease 183
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab 183
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 182
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 180
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? 180
HCV-related mixed cryoglobulinemia and BAFF promoter polymorphism 179
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 177
Involvement of PI3K in HCV-related lymphoproliferative disorders 176
Host genetic determinants in HCV-related mixed cryoglobulinemia 173
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 170
T(14;18) translocation in chronic hepatitis C virus infection 169
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 169
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 168
Genetic determinants in Hepatitis C Virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc-gamma receptors 165
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 164
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 160
Crioglobulinemia e linfoma in corso di infezione da HCV 156
Hepatitis C virus core protein enhances B lymphocyte proliferation 154
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 154
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 153
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 153
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 152
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 148
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 145
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 144
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 141
VALUE OF IL28B GENOTYPING IN PATIENTS WITH HCV-RELATED MIXED CRYOGLOBULINEMIA: RESULTS OF A LARGE, PROSPECTIVE STUDY 141
Il polimorfismo dell'interleuchina 28B come predittore di risposta in pazienti con crioglobulinemia mista HCV-correlata 140
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 133
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 131
Eventi Oncomolecolari nella Crioglobulinemia Mista 128
Long-term outcome of HCV-related mixed cryoglobulinemia in patients achieving sustained viral sustained viral response (SVR) after antiviral therapy 126
IL28B polymorphism as predictor of response to anti-HCV terapy in HCV-related mixed cryoglobulinemia syndrome 124
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 124
HCV core protein induces B lymphocytes proliferation increasing DNP63 expression 114
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 111
Reply: HCV infection and psychopathological disorders 108
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 105
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 103
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 97
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 94
Infezione delle cellule linfatiche da parte del virus C dell’epatite: fatti e controversie 94
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 91
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 91
La cimentazione della proteina CD81 con ligandi specifici promuove la proliferazione di cellule B e l’espressione della proteina c-myc 91
null 48
Totale 9.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022378 0 0 15 15 15 17 16 30 21 9 90 150
2022/20231.154 100 152 75 108 114 226 152 59 124 8 21 15
2023/2024363 17 52 68 28 23 66 7 65 8 8 10 11
2024/20252.856 93 286 178 434 966 368 43 171 99 58 90 70
2025/20262.605 353 345 154 114 251 103 314 104 291 178 62 336
2026/2027342 70 85 187 0 0 0 0 0 0 0 0 0
Totale 9.981